期刊文献+

氟喹诺酮类药物对嗜麦芽窄食单胞菌主动外排泵表型特征研究 被引量:9

Study of phenotypic characterization of efflux mechanism on fluoroquinolones against Stenotrophomonas maltophilia
下载PDF
导出
摘要 目的 研究氟喹诺酮类药物(FQNS)对嗜麦芽窄食单胞菌的抗菌活性及氰氯苯腙(CCCP)对其主动外排泵表型特征的影响。方法 用琼脂二倍稀释法测定FQNS的最低抑菌浓度(MIC),测定CCCP对FQNS的MIC值的影响。结果 111株嗜麦芽窄食单胞菌对FQNS耐药率较低,尤以新型FQNS抗菌活性较高,其中抗菌活性由高到低依次是加替沙星、司帕沙星、左氧氟沙星和环丙沙星。主动外排泵抑制剂CCCP在体外能增强FQNS抗菌活性,主动外排机制即存在于FQNS耐药菌株,也存在于FQNS敏感菌株。但是CCCP对4种FQNS耐药菌株影响更大。结论 主动外排泵抑制剂在体外能降低FQNS对嗜麦芽窄食单胞菌的MIC,若能保证安全性,可能成为临床克服细菌耐药性的一种方法。 Objective To study the fluoroquinolones(FQNS)againstStenotrophomonas maltophilia and the affection of carbonyl cyanide m-chlorophe-nylhydrazone (CCCP) on it. Methods Minimal inhibitory concentrations (MICS) ofantibiotics that of FQNS combined 5 mg.L-1 CCCP against Stenotrophomonasmaltophilia were assayed by two-fold agar dilution method simultaneously.Results Of 111 strains of Stenotrophomonas maltophilia, the resistant ratio ofFQNS were lower, especially new FQNS have stronger antimicrobial activities. Invitro CCCP enhanced the activities of FQNS. Efflux mechanism existed not only inFQNS resistant strains, but also in FQNS sensitive strains. But the affection ofCCCP against FQNS resistant strains was much stronger than that of FQNSsusceptible strains. Conclusion In vitro CCCP decrease the FQNS MICS ofStenotrophomonas maltophilia. If the safety guaranteed, it may be a method whichbe used to overcome the bacterial resistances in clinic.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2004年第5期381-384,共4页 The Chinese Journal of Clinical Pharmacology
关键词 嗜麦芽窄食单胞菌 耐药 氰氯苯腙 氟喹诺酮 Stenotrophomonas maltophilia drug resistance carbonyl cyanide m-chlorophenylhydrazone fluoroquinolone
  • 相关文献

参考文献9

  • 1Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia[J]. Clin Microbiol Rev, 1998;11:57-80.
  • 2National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing[S]. Pennsylvania(USA):NCCLS, 2002; 22(12 Suppl.):S90.
  • 3Valdezate S, Vindel A, Echeita A, et al. Topiosomerase Ⅱ and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility[J]. Antimicrob Agents Chemother, 2002;46:665-671.
  • 4Betriu C, Sanchez A, Palan L,etal. Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999[J]. J Antimicrob Chemother, 2001;48:152-154.
  • 5Weiss K, Restieri C, Carolis ED, et al. Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia[J]. J Antimicrob Chermother, 2000;45:363-365.
  • 6Poole K.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria[J]. Antimicrob Agents Chemother, 2000;44:2233-2241.
  • 7Webber MA, Piddock LJV. The importance of efflux pumps in bacterial antibiotic resistance[J]. JAntimicrob Chemother, 2003;51:9-11.
  • 8Ribera A, Jurado A, Ruiz J, et al. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas rmaltophilia clinical isolates in the presence and absence of reserpine[J]. Diag Microbiol Infect Dis, 2002;42:123-128.
  • 9Lomovskaya O, Warren MS, Lee A, et al. Identification and characterization of inhibitors of multidrug resistance effiux pumps in Pseudomonas aeruginosa: novel agents for combination therapy[J].Antimicrob Agents Chemother, 2001 ;45:105-116.

同被引文献74

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部